OpenEvidence has expanded its collaboration with NewYork-Presbyterian, Columbia University Vagelos College of Physicians and Surgeons, and Weill Cornell Medicine to deploy its clinical AI platform across one of the largest academic healthcare networks in the United States. The rollout will make OpenEvidence’s AI-powered clinical decision support tools available throughout NewYork-Presbyterian’s hospitals and care sites across New York City and Westchester, giving physicians and other clinicians access to evidence-based medical information directly within their daily workflows.
The platform enables healthcare professionals to ask complex clinical questions in natural language and receive responses grounded in peer-reviewed research, clinical guidelines and medical evidence. By providing rapid access to current medical knowledge at the point of care, the organizations aim to support more informed clinical decision-making while maintaining physician oversight. The deployment is intended to benefit clinicians working across a wide range of specialties and practice settings, rather than limiting AI access to individual departments or pilot programs.
For OpenEvidence, the partnership significantly expands its presence within a major academic health system that includes multiple hospitals, outpatient clinics, medical groups and telemedicine services. The collaboration also reflects the growing adoption of AI-powered clinical decision support tools by leading healthcare institutions as they seek to integrate artificial intelligence into routine care while preserving evidence-based standards and patient safety. More broadly, the agreement highlights increasing momentum for enterprise-wide AI deployments that help clinicians navigate rapidly expanding medical knowledge without replacing clinical judgment.
Click here to read the original news story.
